Essential Thrombocythemia: A Case Study - Jerry L. Spivak, MD Published 2019-11-20 Download video MP4 360p Download video MP4 720p Recommendations 29:30 Joseph Scandura, MD PhD - Managing Essential Thrombocythemia in 2023 32:34 Current Management of Polycythemia Vera - Richard T. Silver, MD 1:28:02 CR&T Virtual Symposium 2020 - Presentations, Part 2 29:13 Essential Thrombocythemia: Pathogenesis and Management 1:30:12 Conversation with an MPN Specialist: Focusing on Essential Thrombocythemia 1:03:18 Making Rounds: Medical Education Documentary Film 32:29 Current Developments in Polycythemia Vera Treatment: Is It Curable? 1:46:17 Argye Hillis: Advances in Diagnosis, Prognosis, and Treatment of Primary Progressive Aphasia 13:30 Why Europe and America’s dying forests could be good news 23:14 Why is Hydroxyurea First Line Therapy in the US for Essential Thrombocythemia? 26:45 Angela Fleischman, MD, PhD - Inflammation in MPNs 37:29 Richard T. Silver, MD - Managing Polycythemia Vera in 2023 19:56 Polycythemia Vera (PV) | Myeloproliferative Neoplasm (MPN) | Erythrocytosis 29:44 Diet, Exercise, and Mindfulness - Robyn Scherber, MD, MPH 2:01:47 Conversation with MPN Specialists: Focus on Essential Thrombocythemia 13:59 Essential Thrombocythemia 54:01 "Chiari I Malformation: The 'Cover Up'" - Judy Huang, MD 09:35 What is essential thrombocythemia? 17:46 Evaluating and managing "Triple Negative" MPN 56:26 Strategies for Management of Atrial Fibrillation: State of the Art in 2023 Similar videos 33:14 Natural History and Heredity - Jerry L. Spivak, MD 13:08 Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa 01:03 MOST: an observational study of myelofibrosis and essential thrombocythemia 22:40 Treatment goals in Essential Thrombocythemia and Polycythemia vera 30:45 Jerry Spivak, MD - Managing Myelofibrosis in 2023 05:21 Challenges in the treatment and management of ET and the need to improve therapeutic approaches 08:14 Chronic Blood Cancer At 30 | Essential Thrombocytosis | MPN 01:26 Agents of interest being explored in essential thrombocythemia and polycythemia vera 01:29 Dr. Spivak on the Prevalence of Polycythemia Vera 03:40 Results of the phase 4 EXELS study of high-risk patients with essential thrombocythemia 04:58 Quick hematology revision | Essential thrombocythemia | Diagnostic criteria | Microscopy 02:43 Case 3: Low- to Intermediate- Risk Essential Thrombocythemia 03:14 Interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia 01:57 SURPASS ET: P1101 in essential thrombocythemia 16:19 Latest on Current Treatments for Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia More results